Advanced Analysis Free Trading Signals Real Time Alerts

Uber Stock Gains As it Announces On-Demand Prescription Delivery Expansion In Washington, DC

Practice Stock Trading Your capital is at risk
Updated: 13 May 2021

Shares of Uber (NYSE: UBER) are trading higher on Thursday, after the company and technology company Nimble announced the expansion of their partnership and launch of on-demand prescription delivery in Washington, DC.

All Uber Eats customers in the region will now have access to prescription delivery in as little as an hour, a statement read.

Uber's share price rose over 3% to $45.26 following the news.


Users can transfer existing prescriptions — or fulfil new ones — from neighbourhood pharmacies from the Uber Eats app.

Nimble will use its network of pharmacies to coordinate fulfilment, with Uber Eats delivering the prescription directly to consumers. Prescriptions that are paid for by any government healthcare program are ineligible.

“We’re thrilled to be partnering with Nimble to bring quick, on-demand prescription delivery to folks across D.C.,” said Michele Blackwell, head of Mid-Atlantic Policy for Uber.

“People are always looking for ways to conveniently and safely get the things they need — whether that be food, other everyday essentials, or even medicine, and we’re proud that Uber is now playing a role in bringing prescriptions right to customers’ doorsteps,” he added.

The expansion follows Uber's successful prescription delivery launch in New York City, Chicago, Atlanta, Miami, Los Angeles, San Diego, and Orange County. The service is also launching today in Seattle.

Should You Invest in Uber Shares?

One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It's a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 68 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .